The pharmaceutical landscape experiencing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 aod9604 peptide diabetes and, progressively, are being explored for their therapeutic efficacy in other conditions like obesity and cardiovascul